HealthAugust 12, 2026
quizartinib
kwiz-AR-ti-nib
Definition
A targeted drug therapy, specifically a FLT3 inhibitor, being studied by Kura Oncology as part of a combination regimen for treating acute myeloid leukemia (AML).
Etymology
The name is a constructed pharmaceutical brand or generic drug name; like many modern oncology drugs, it combines roots (here likely referencing 'quiz-' and '-art-' associated with early developmental codes) with the standard '-nib' suffix, which denotes a kinase inhibitor.
In the news
In this article, quizartinib is mentioned as part of a 'quadruplet' combination trial that Kura is investigating to enhance the efficacy of their lead drug in frontline AML patients.
Earnings call transcript: Kura Oncology tops Q2 2026 estimates as launch gains
Read the full article ↗Investing.com